Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Change in Taxes: 2014-2025

Historic Change in Taxes for Theravance Biopharma (TBPH) over the last 2 years, with Sep 2025 value amounting to -$22.6 million.

  • Theravance Biopharma's Change in Taxes was N/A to -$22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.8 million, marking a year-over-year change of. This contributed to the annual value of $258,000 for FY2020, which is 93.03% down from last year.
  • Per Theravance Biopharma's latest filing, its Change in Taxes stood at -$22.6 million for Q3 2025, which was down 7,768.47% from $295,000 recorded in Q4 2020.
  • Theravance Biopharma's Change in Taxes' 5-year high stood at -$22.6 million during Q3 2025, with a 5-year trough of -$22.6 million in Q3 2025.
  • Its 1-year average for Change in Taxes is -$22.6 million, with a median of -$22.6 million in 2025.